Atypical Chronic Myeloid Leukemia
specificA myelodysplastic/myeloproliferative neoplasm characterized by the presence of leukocytosis with increased numbers of neutrophils, promyelocytes, myelocytes, and metamyelocytes; blasts less than 20% in bone marrow and peripheral blood; dysgranulopoiesis; minimal or absent monocytosis; absence of eosinophilia; and presence of bone marrow hypercellularity with granulocytic proliferation and granulocytic dysplasia. Dysplasia in the erythroid and megakaryocytic lineages may be present or absent. No
8
Centers
6
Active Trials
—
Cancer Funding
Top Centers for Atypical Chronic Myeloid Leukemia(8)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 61.9 |
| 2 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 61.9 |
| 3 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 61.9 |
| 4 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 61.9 |
| 5 | Wilmot Cancer Institute, UR MedicineRochester, NY NCI Clinical Active Research Program | 61.9 |
| 6 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 61.9 |
| 7 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 39.4 |
| 8 | UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 39.4 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →